Revenue
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Capricor Therapeutics, Inc. (CAPR)
Price$9.40Cached quote
Net income
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $22.3M | $25.2M | $2.6M | $244,898 | $310,250 | $1.0M | $1.7M | $2.7M | $4.0M | $5.5M | $4.8M | $503,233 | $195,500 | $1.4M | — | — | — | — | — |
| Research & development | $84.5M | $50.0M | $36.4M | $21.8M | $13.6M | $8.5M | $5.1M | $12.1M | $10.8M | $16.0M | $13.8M | $7.8M | $5.2M | $2.6M | $4.1M | $4.1M | — | — | — | — |
| Operating expenses | $108.1M | $64.8M | $49.3M | $32.2M | $21.2M | $14.0M | $8.7M | $17.0M | $15.5M | $21.0M | $18.1M | $10.8M | $7.4M | $4.0M | $6.3M | $6.3M | — | — | — | — |
| Operating income | −$108.1M | −$42.6M | −$24.1M | −$29.7M | −$20.9M | −$13.7M | −$7.7M | −$15.3M | −$12.9M | −$17.0M | −$12.6M | −$6.0M | −$6.9M | −$2.1M | −$4.9M | −$6.3M | — | — | — | — |
| Operating margin | — | −191.12% | −95.63% | −1,163.93% | −8,549.86% | −4,412.56% | −769.52% | −917.04% | −482.40% | −424.56% | −228.57% | −125.72% | −1,371.71% | −1,074.19% | −361.70% | — | — | — | — | — |
| EBITDA | −$106.3M | −$41.1M | −$23.0M | −$29.2M | −$20.7M | −$13.5M | −$7.6M | −$15.2M | −$12.7M | −$16.9M | −$12.5M | −$6.0M | −$6.9M | −$2.1M | −$4.9M | −$6.3M | — | — | — | — |
| EBITDA margin | — | −184.72% | −91.39% | −1,143.04% | −8,449.54% | −4,366.18% | −752.41% | −907.61% | −476.99% | −421.42% | −226.56% | −124.85% | −1,366.36% | −1,063.79% | −361.14% | — | — | — | — | — |
| Net income | −$105.0M | −$40.5M | −$22.3M | −$29.0M | −$20.0M | −$13.7M | −$7.6M | −$15.2M | $2.4M | −$18.8M | −$12.9M | −$6.2M | −$8.9M | −$2.1M | −$1.1M | −$1.1M | −$148,970 | −$630,859 | −$979,076 | −$1.2M |
| Net profit margin | — | −181.71% | −88.52% | −1,137.37% | −8,175.86% | −4,401.94% | −760.36% | −908.91% | 91.19% | −470.33% | −233.02% | −129.87% | −1,766.96% | −1,059.47% | −84.85% | — | — | — | — | — |
| Basic EPSper basic share | -$2.26 | -$1.15 | -$0.83 | -$1.18 | -$0.87 | -$0.88 | -$2.06 | -$5.17 | $10.00 | -$101.00 | -$81.00 | -$53.00 | -$85.00 | -$21.00 | -$13.00 | -$19.00 | — | — | — | — |
| Diluted EPSper diluted share | -$2.26 | -$1.15 | -$0.83 | -$1.18 | -$0.87 | -$0.88 | -$2.06 | -$52.00 | $9.00 | -$101.00 | -$81.00 | -$53.00 | -$85.00 | -$21.00 | -$13.00 | -$19.00 | — | — | — | — |
Owners
Reported shareholders
≈12.20%of listed shares
Nippon Shinyaku Co Ltd7.09M shares · Sep 20, 2024
View holders
| Holder | % owned |
|---|---|
Nippon Shinyaku Co Ltd | ≈12.20%7.09M shares |
BlackRock, Inc. | 7.13%4.15M shares |
TANG CAPITAL MANAGEMENT LLC | 7.06%4.1M shares |
MONTANOVA CAPITAL, LLC | 7.04%4.09M shares |
STATE STREET CORP | 5.85%3.4M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.95%2.3M shares |
GOLDMAN SACHS GROUP INC | 2.72%1.58M shares |
RA CAPITAL MANAGEMENT, L.P. | 2.59%1.51M shares |
Boxer Capital Management, LLC | 2.40%1.4M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.36%1.37M shares |
FMR LLC | 1.96%1.14M shares |
CITADEL ADVISORS LLC | 1.40%814.44K shares |
MERCER GLOBAL ADVISORS INC /ADV | 1.38%802.73K shares |
Soleus Capital Management, L.P. | 1.31%761.74K shares |
MORGAN STANLEY | 1.18%684.52K shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 1.09%636.09K shares |
UBS Group AG | 1.07%619.66K shares |
DG Capital Management, LLC | 1.05%611.6K shares |
Ikarian Capital, LLC | 1.04%604.22K shares |
NORTHERN TRUST CORP | 0.87%503.53K shares |
Percentages use 58.11M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 25, 2026Form 4 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | SellCommon Stock | 24.1K | $30.38 | $732.2K | 11.2K |
| Jun 25, 2026Form 4 | Krasney KarenEVP, GENERAL COUNSEL | SellCommon Stock | 24.1K | $30.38 | $732.2K | 30.5K |
| Jun 24, 2026Form 4 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | SellCommon Stock | 400 | $30.00 | $12.0K | 11.2K |
| Jun 24, 2026Form 4 | Krasney KarenEVP, GENERAL COUNSEL | SellCommon Stock | 400 | $30.00 | $12.0K | 30.5K |
| Jun 22, 2026Form 4 | Bergmann AnthonyCHIEF FINANCIAL OFFICER | SellCommon Stock | 500 | $30.00 | $15.0K | 11.2K |